
What you'll get: an initial provider review and/or telehealth visit...
What you'll get: an initial provider review and/or telehealth visit...
What you'll get: an initial provider review and/or telehealth visit...
What you'll get: an initial provider review and/or telehealth visit...
What you'll get: an initial provider review and/or telehealth visit...
What you'll get: an initial provider review and/or telehealth visit...
*FDA-approved medications such as Saxenda®, Victoza®, Wegovy®, and Ozempic® are proprietary to Novo Nordisk™, while Mounjaro® and Zepbound™ are products of Eli Lilly and Company™.
VitalCore Health offers compounded versions of GLP-1s when medically appropriate and legally permissible. These compounded medications are prepared by licensed pharmacies in accordance with Section 503A of the Federal Food, Drug, and Cosmetic Act. Compounded drugs are not FDA-approved. This means they do not undergo FDA premarket review for safety, efficacy, or manufacturing quality. Compounded medications may play an important role for patients whose needs cannot be met by commercially available drugs, but they have not been demonstrated to the FDA to be safe or effective for any particular use.